AEOLUS(SH:600469)2020-04-29 16:00Financial Performance - Operating revenue decreased by 24.18% to CNY 1,065,838,737.09 year-on-year[5] - Net profit attributable to shareholders dropped by 76.96% to CNY 20,381,975.81 compared to the same period last year[5] - Basic earnings per share decreased by 75.00% to CNY 0.04 compared to the previous year[5] - The weighted average return on net assets decreased by 3.34 percentage points to 0.97%[5] - Total operating revenue for Q1 2020 was ¥1,065,838,737.09, a decrease of 24.2% compared to ¥1,405,695,517.92 in Q1 2019[26] - Net profit for Q1 2020 was ¥20,381,975.81, a decline of 77.0% from ¥88,448,375.90 in Q1 2019[27] - The company reported a total profit of ¥27,468,815.02 for Q1 2020, down 75.0% from ¥109,624,129.47 in Q1 2019[27] - Total comprehensive income for Q1 2020 was ¥19,752,594.71, a decrease of 77.7% from ¥88,779,875.90 in Q1 2019[27] Assets and Liabilities - Total assets increased by 1.39% to CNY 7,332,908,716.96 compared to the end of the previous year[5] - The company's total liabilities reached ¥5,012,142,800.04, compared to ¥4,943,510,545.56, marking an increase of approximately 1.39%[24] - Current liabilities totaled ¥4,104,537,796.31, up from ¥4,033,712,830.49, indicating an increase of about 1.75%[24] - Shareholders' equity rose to ¥2,504,021,229.27 from ¥2,463,080,830.41, representing an increase of about 1.67%[24] - Total liabilities reached ¥5,135,521,306.89, with current liabilities at ¥4,225,723,591.82 and non-current liabilities at ¥909,797,715.07[40] Cash Flow - Cash flow from operating activities increased by 81.69% to CNY 76,005,515.84 year-on-year[5] - The net cash flow from operating activities for Q1 2020 was ¥76.01 million, a significant increase from ¥41.83 million in Q1 2019, representing an increase of 81.5%[33] - The total cash inflow from operating activities in Q1 2020 was ¥987.17 million, compared to ¥879.29 million in Q1 2019, indicating an increase of 12.3%[35] - The total cash outflow from operating activities in Q1 2020 was ¥898.49 million, a decrease from ¥929.37 million in Q1 2019, reflecting a decline of 3.3%[35] - The company reported a net cash outflow from financing activities of ¥80,539,701.61, a decrease of 66.77% compared to the previous period[14] Shareholder Information - The total number of shareholders reached 25,925 by the end of the reporting period[10] - The largest shareholder, China National Chemical Corporation, holds 44.58% of the shares[11] Research and Development - Research and development expenses were ¥43,884,807.84, reflecting a significant increase due to technology usage fees[14] - Research and development expenses increased to ¥43,884,807.84 in Q1 2020, compared to a negative expense of -¥16,028,759.31 in Q1 2019[26] Other Income and Expenses - Non-recurring gains and losses amounted to CNY 15,041,489.49, primarily from government subsidies[7] - Other income surged by 179.34% to ¥16,880,175.07 from ¥6,042,922.29, attributed to increased government subsidies[14] - Financial expenses dropped by 54.30% to ¥14,678,088.79 from ¥32,118,938.47, due to increased foreign exchange gains[14] Challenges and Developments - The company is facing challenges in advancing a major asset restructuring transaction due to significant obstacles[15] - The company has not disclosed any new product developments or market expansion strategies in this report[5]